S
Synergia Medical
Optoelectronic neurostimulator for drug-resistant, MRI-compatible epilepsy treatment
About Synergia Medical
Manufacturer of medical devices intended to focus on optoelectronics-related technology. The company's device focuses on building MRI-safe, implanted neurostimulation devices for drug-resistant epilepsy with a range of further therapeutic applications wherein wires are replaced by fiber optics and photovoltaic cells convert optical energy into electrical impulses, enabling medical organizations to receive implantable neurostimulators for their patients.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 21
- Open positions
- None listed
- Dealroom signal
- 59.9/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, Medical Devices
- Sector
- Neurology, Electro-Optics, Neuromodulation and Neurostimulation, Sustainable Development Goals, EIC, Semiconductor IP
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B, B2C
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Jan 2023 | $4.2M | $50M | Berrebi Family Office | ↗ |
| SERIES B✓Equity / VC | Sep 2022 | $9.9M | $40M | TCD Capital · SFPIM · Orsa · Public Service of Wallonia | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Synergia Medical is 470 monthly website visits, up 147.4% over the last three months. Synergia Medical's team declined 27.6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Synergia Medical in the Mont-Saint-Guibert ecosystem
The Synergia Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
European Innovation Council
Series A6 investors entered at this stage
Newton BioCapital
SFPIM
TCD Capital
Orsa
Public Service of Wallonia- BOBerrebi Family Office
Other known investors3 additional known investors
Invest.BW
Wallonie Entreprendre
WE Venture
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Synergia Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Synergia Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








